Tenaya Therapeutics and Alnylam Pharmaceuticals have agreed to collaborate on identifying potential new gene therapies for the treatment of cardiovascular disease. Tenaya will receive an upfront payment of $10 million, but stands to earn much more.
Freestanding EDs demonstrated meaningful operational advantages over hospitals when using an accelerated troponin pathway. This included earlier discharges for low-risk chest pain patients.
The AI model showcased an ability to accurately identify signs of pulmonary hypertension in retinal images. "This opens the possibility of using a simple photograph to gain insights into a premature infant's overall health," one researcher explained.
The AI-powered Relief System is able to modulate venous pressure using hemodynamic data. The goal is to help patients better manage heart failure congestion at home.
STS plans on using new research out of Mayo Clinic to help with the development of a surgical risk calculator for adults with this challenging condition.
The popular SGLT2 inhibitor, sold by Boehringer Ingelheim and Eli Lilly and Company under the name Jardiance, has already been approved by the FDA to treat type 2 diabetes and heart failure.
Both ChatGPT and GPT-4 were found to be be good at analyzing free-text notes for lung cancer insights. One of the two programs, however, was able to outperform the other.
Researchers from Case Western Reserve University are commissioning a study to determine if a novel MRI technique can predict the effectiveness of chemotherapy in treating breast cancer.
Hospital patients who test positive for Clostridioides difficile immediately upon admission but show no symptoms are highly unlikely to spread the germ to other inpatients.
Reviewing 20 years’ worth of data, researchers have found children with Down syndrome are imaged more often than others and, in the process, get exposed to significantly more ionizing radiation.
Some heart teams may only target the culprit lesions when treating older patients, but new research confirms this increases the risk of several unfavorable outcomes.
